SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Suortti Tapani M.)
 

Sökning: WFRF:(Suortti Tapani M.) > (2010) > Splanchnic balance ...

  • Westerbacka, JukkaDepartment of Medicine, Division of Diabetes, University of Helsinki, Helsinki, Finland (författare)

Splanchnic balance of free fatty acids, endocannabinoids, and lipids in subjects with nonalcoholic fatty liver disease

  • Artikel/kapitelEngelska2010

Förlag, utgivningsår, omfång ...

  • Saunders Elsevier,2010
  • printrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:oru-63633
  • https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-63633URI
  • https://doi.org/10.1053/j.gastro.2010.06.064DOI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:121672407URI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • Funding agencies:Academy of FinlandSigrid Juselius FoundationFinnish Diabetes Research FoundationOrion FoundationJalmari and Rauha Ahokas FoundationBiomedicum Helsinki FoundationNovo Nordisk FoundationEuropean Commission LSHM-CT-2005-018734
  • BACKGROUND & AIMS: Animal studies suggest that endocannabinoids could contribute to the development of nonalcoholic fatty liver disease (NAFLD). In addition, NAFLD has been shown to be associated with multiple changes in lipid concentrations in liver biopsies. There are no data on splanchnic free fatty acid (FFA), glycerol, ketone body, endocannabinoid, and lipid fluxes in vivo in subjects with NAFLD.METHODS: We performed hepatic venous catheterization studies in combination with [(2)H(2)]palmitate infusion in the fasting state and during a low-dose insulin infusion in 9 subjects with various degrees of hepatic steatosis as determined using liver biopsy. Splanchnic balance of endocannabinoids and individual lipids was determined using ultra performance liquid chromatography coupled to mass spectrometry.RESULTS: Concentrations of the endocannabinoid 2-arachidonoylglycerol were higher in arterialized (91 ± 33 μg/L basally) than in hepatic venous (51 ± 19 μg/L; P < .05) plasma. Fasting arterial (r = 0.72; P = .031) and hepatic venous (r = 0.70; P = .037) concentrations of 2-arachidonoylglycerol were related positively to liver fat content. Analysis of fluxes of 85 different triglycerides showed that the fatty liver overproduces saturated triglycerides. In the plasma FFA fraction in the basal state, the relative amounts of palmitoleate and linoleate were lower and those of stearate and oleate were higher in the hepatic vein than in the artery. Absolute concentrations of all nontriglyceride lipids were comparable in arterialized venous plasma and the hepatic vein both in the basal and insulin-stimulated states.CONCLUSIONS: The human fatty liver takes up 2-arachidonoylglycerol and overproduces triacylglycerols containing saturated fatty acids, which might reflect increased de novo lipogenesis.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Kotronen, AnnaDepartment of Medicine, Division of Diabetes, University of Helsinki, Helsinki, Finland: Minerva Medical Research Institute, Helsinki, Finland; Diabetes Prevention Unit, National Institute for Health and Welfare, Helsinki, Finland (författare)
  • Fielding, Barbara A.Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, United Kingdom (författare)
  • Wahren, JohnKarolinska Institutet (författare)
  • Hodson, LeanneOxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, United Kingdom (författare)
  • Perttilä, JuliaMinerva Medical Research Institute, Helsinki, Finland (författare)
  • Seppänen-Laakso, TuulikkiVTT Technical Research Centre of Finland, Espoo, Finland (författare)
  • Suortti, TapaniVTT Technical Research Centre of Finland, Espoo, Finland (författare)
  • Arola, JohannaDepartment of Pathology, University of Helsinki and HUSLAB, Helsinki, Finland (författare)
  • Hultcrantz, RolfKarolinska Institutet (författare)
  • Castillo, SandraVTT Technical Research Centre of Finland, Espoo, Finland (författare)
  • Olkkonen, Vesa M.Minerva Medical Research Institute, Helsinki, Finland (författare)
  • Frayn, Keith N.Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, United Kingdom (författare)
  • Oresic, Matej,1967-VTT Technical Research Centre of Finland, Espoo, Finland(Swepub:oru)moc (författare)
  • Yki-Järvinen, HanneleDepartment of Medicine, Division of Diabetes, University of Helsinki, Helsinki, Finland (författare)
  • Department of Medicine, Division of Diabetes, University of Helsinki, Helsinki, FinlandDepartment of Medicine, Division of Diabetes, University of Helsinki, Helsinki, Finland: Minerva Medical Research Institute, Helsinki, Finland; Diabetes Prevention Unit, National Institute for Health and Welfare, Helsinki, Finland (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:Gastroenterology: Saunders Elsevier139:6, s. 1961-1971.e10016-50851528-0012

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy